Should You Buy It: Albemarle Offers Growth at a Good Price
Albemarle(ALB Quote) shares fell more than 9% Tuesday -- their biggest drop in eight years -- after the specialty chemicals maker posted disappointing fourth-quarter results Monday evening.
The company makes a wide range of specialty chemicals, including flame retardants, curatives and even bulk ibuprofen. Albemarle also sells to a wide range of industries, including plastics, pharmaceutical and energy companies.
Albermarle earned 60 cents a share, which was down from 65 cents a year ago, but a penny ahead of the consensus analyst estimate. Revenue rose 2.5% from the previous year to $599.2 million, but fell $12 million short of expectations. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,309.92 | 1,091.49 | 2,138.44 | 32.31 |
Oil *
77.12
|
|
DOWN
154.48
|
DOWN
19.14
|
DOWN
37.61
|
DOWN
0.48
|
10 Yr
3.23%
SPDR Gold
115.06
|
|
-1.48%
|
-1.72%
|
-1.73%
|
-1.46%
|
Data delayed 20 minutes |


Connect with TheStreet